Autopsy report · NCT00772629
Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults
Cause of deathNo reason given
“See detailed description for termination reason”
Life of this trial
- Registered 4 years 9 months after it had already started.
- Ran for about 3 months before it stopped.
- 18 participants enrolled.
- Results were posted on the registry 5 years after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Sponsor type
- Industry
- Conditions
- Meningitis; Meningococcemia
- Interventions
- Meningococcal Polysaccharide Diphtheria Toxoid Conjugate; Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
- Participants
- 18
- Sites
- 2
- Countries
- United Kingdom
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.